← Back to headlines
Dyne Therapeutics stock up 40% despite biotech fund selling shares
Dyne Therapeutics stock has seen a significant 40% increase, even as a biotech fund recently disclosed selling $14 million worth of its shares. This divergence in activity presents an interesting market dynamic for the company.
19 May, 17:37 — 19 May, 17:37
Sources
Showing 1 of 1 sources
